Detalhe da pesquisa
1.
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.
mBio
; 13(2): e0370521, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35229634